The invention concerns antigens for the production of antibodies to Platelet Activating Factor (PAF). The antigens are PAF analogues of formula (I) STR1 wherein X comprises a high molecular weight group, R1 is a linking group and R2 to R5 are selected from C1 to C6 alkyl. Other aspects of the invention include PAF-antibodies produced using said antigens, labelled PAF analogues, intermediates for the preparation of PAF analogues and methods and a kit for the immunoassay of PAF.
-
(2008/06/13)
More Articles about upstream products of 119142-18-6